|
US4916135A
(en)
|
1989-05-08 |
1990-04-10 |
Hoechst Roussel Pharmaceuticals Inc. |
N-heteroaryl-4-quinolinamines
|
|
US5710158A
(en)
*
|
1991-05-10 |
1998-01-20 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
|
PT100905A
(pt)
|
1991-09-30 |
1994-02-28 |
Eisai Co Ltd |
Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
|
|
GB9300059D0
(en)
|
1992-01-20 |
1993-03-03 |
Zeneca Ltd |
Quinazoline derivatives
|
|
GB9510757D0
(en)
|
1994-09-19 |
1995-07-19 |
Wellcome Found |
Therapeuticaly active compounds
|
|
US5747498A
(en)
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
|
US6046206A
(en)
|
1995-06-07 |
2000-04-04 |
Cell Pathways, Inc. |
Method of treating a patient having a precancerous lesions with amide quinazoline derivatives
|
|
EP0912559B1
(en)
|
1996-07-13 |
2002-11-06 |
Glaxo Group Limited |
Fused heterocyclic compounds as protein tyrosine kinase inhibitors
|
|
WO1998005647A1
(en)
|
1996-08-01 |
1998-02-12 |
Dow Agrosciences Llc |
Quinolinium derivatives having fungicidal activity
|
|
US6809097B1
(en)
|
1996-09-25 |
2004-10-26 |
Zeneca Limited |
Quinoline derivatives inhibiting the effect of growth factors such as VEGF
|
|
UA73073C2
(uk)
|
1997-04-03 |
2005-06-15 |
Уайт Холдінгз Корпорейшн |
Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція
|
|
GB9800569D0
(en)
|
1998-01-12 |
1998-03-11 |
Glaxo Group Ltd |
Heterocyclic compounds
|
|
BR9914162A
(pt)
|
1998-10-01 |
2001-06-26 |
Astrazeneca Ab |
Derivado de amida, processo para preparar um derivado de amida, ou um sal farmaceuticamente aceitável ou éster clivável in vivo do mesmo, composição farmacêutica e uso de um derivado de amida, ou um sal farmaceuticamente aceitável ou éster clivável in vivo do mesmo
|
|
GB2345486A
(en)
|
1999-01-11 |
2000-07-12 |
Glaxo Group Ltd |
Heteroaromatic protein tyrosine kinase inhibitors
|
|
CZ20021009A3
(cs)
|
1999-09-21 |
2002-06-12 |
Astrazeneca Ab |
Deriváty chinazolinu, způsob jejich přípravy a jejich pouľití jako léčiv
|
|
EP1294709A2
(en)
|
2000-01-28 |
2003-03-26 |
AstraZeneca AB |
Quinoline derivatives and their use as aurora 2 kinase inhibitors
|
|
AU2001237041B9
(en)
|
2000-02-17 |
2005-07-28 |
Amgen Inc. |
Kinase inhibitors
|
|
US6521618B2
(en)
|
2000-03-28 |
2003-02-18 |
Wyeth |
3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
|
|
US6589758B1
(en)
|
2000-05-19 |
2003-07-08 |
Amgen Inc. |
Crystal of a kinase-ligand complex and methods of use
|
|
EP1313726A1
(en)
|
2000-08-09 |
2003-05-28 |
AstraZeneca AB |
Quinoline derivatives having vegf inhibiting activity
|
|
US6548508B2
(en)
|
2000-10-20 |
2003-04-15 |
Pfizer, Inc. |
Use of PDE V inhibitors for improved fecundity in mammals
|
|
GB0104422D0
(en)
|
2001-02-22 |
2001-04-11 |
Glaxo Group Ltd |
Quinoline derivative
|
|
UY27225A1
(es)
|
2001-03-23 |
2002-10-31 |
Bayer Corp |
Inhibidores de la rho-quinasa
|
|
MXPA03008658A
(es)
|
2001-03-23 |
2005-04-11 |
Bayer Ag |
Inhibidores de rho-cinasa.
|
|
SE0101675D0
(sv)
|
2001-05-11 |
2001-05-11 |
Astrazeneca Ab |
Novel composition
|
|
US7115617B2
(en)
|
2001-08-22 |
2006-10-03 |
Amgen Inc. |
Amino-substituted pyrimidinyl derivatives and methods of use
|
|
WO2003026666A1
(en)
|
2001-09-26 |
2003-04-03 |
Bayer Pharmaceuticals Corporation |
2-phenylamino-4- (5-pyrazolylamino)-pyrimidine derivatives as kinase inhibitors, in particular, as src kinase inhibitors
|
|
NZ533440A
(en)
|
2001-12-24 |
2006-08-31 |
Astrazeneca Ab |
Substituted quinazoline derivatives as inhibitors of aurora kinases
|
|
US7645878B2
(en)
|
2002-03-22 |
2010-01-12 |
Bayer Healthcare Llc |
Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof
|
|
TWI275390B
(en)
|
2002-04-30 |
2007-03-11 |
Wyeth Corp |
Process for the preparation of 7-substituted-3- quinolinecarbonitriles
|
|
AU2003255482A1
(en)
*
|
2002-10-02 |
2004-04-23 |
Merck Patent Gmbh |
Use of 4 amino-quinazolines as anti cancer agents
|
|
WO2004037814A1
(en)
|
2002-10-25 |
2004-05-06 |
Vertex Pharmaceuticals Incorporated |
Indazolinone compositions useful as kinase inhibitors
|
|
US20040122161A1
(en)
|
2002-12-21 |
2004-06-24 |
Paul Charles W. |
Hot melt adhesive based on acrylic block copolymers
|
|
CN101074227B
(zh)
*
|
2002-12-24 |
2010-09-29 |
阿斯利康(瑞典)有限公司 |
膦酰氧基喹唑啉衍生物及其药物用途
|
|
PT1578755E
(pt)
|
2002-12-24 |
2007-10-19 |
Astrazeneca Ab |
Derivados de fosfonooxiquinazolina e sua utilização farmacêutica
|
|
TWI328009B
(en)
|
2003-05-21 |
2010-08-01 |
Glaxo Group Ltd |
Quinoline derivatives as phosphodiesterase inhibitors
|
|
WO2004106308A1
(en)
|
2003-05-27 |
2004-12-09 |
Pfizer Products Inc. |
Quinazolines and pyrido [3,4-d] pyrimidines as receptor tyrosine kinase inhibitors
|
|
AU2004253967B2
(en)
|
2003-07-03 |
2010-02-18 |
Cytovia, Inc. |
4-arylamino-quinazolines as activators of caspases and inducers of apoptosis
|
|
US7569577B2
(en)
|
2003-09-16 |
2009-08-04 |
Astrazeneca Ab |
Quinazoline derivatives as tyrosine kinase inhibitors
|
|
WO2005030140A2
(en)
|
2003-09-26 |
2005-04-07 |
Exelixis, Inc. |
C-met modulators and methods of use
|
|
AP2006003619A0
(en)
|
2003-12-23 |
2006-06-30 |
Pfizer |
Novel quinoline derivatives
|
|
CN1934100A
(zh)
|
2004-03-23 |
2007-03-21 |
万有制药株式会社 |
取代喹唑啉或吡啶并嘧啶衍生物
|
|
US20070299092A1
(en)
|
2004-05-20 |
2007-12-27 |
Wyeth |
Quinone Substituted Quinazoline and Quinoline Kinase Inhibitors
|
|
US7531570B2
(en)
|
2004-05-27 |
2009-05-12 |
Vertex Pharmaceuticals Incorporated |
Treatment of diseases using ICE inhibitors
|
|
WO2005120509A1
(en)
|
2004-06-04 |
2005-12-22 |
Amphora Discovery Corporation |
Quinoline- and isoquinoline-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof
|
|
FR2873695A1
(fr)
|
2004-07-30 |
2006-02-03 |
Palumed Sa |
Molecules hybrides qa ou q est une aminoquinoleine et a est un antibiotique ou un inhibiteur de resistance), leur synthese et leurs utilisations en tant qu'agent antibacterien
|
|
MX2007005408A
(es)
*
|
2004-11-09 |
2007-05-16 |
Hoffmann La Roche |
Compuestos de aminoquinazolinas.
|
|
DE502005008351D1
(de)
|
2004-12-22 |
2009-11-26 |
Bayer Schering Pharma Ag |
Chinolinderivat, dessen verwendung, herstellung und dieses enthaltendes arzneimittel
|
|
US8258145B2
(en)
|
2005-01-03 |
2012-09-04 |
Myrexis, Inc. |
Method of treating brain cancer
|
|
CA2603748A1
(en)
|
2005-04-06 |
2006-10-12 |
Exelixis, Inc. |
C-met modulators and methods of use
|
|
JO2787B1
(en)
|
2005-04-27 |
2014-03-15 |
امجين إنك, |
Alternative amide derivatives and methods of use
|
|
EP1746096A1
(en)
|
2005-07-15 |
2007-01-24 |
4Sc Ag |
2-Arylbenzothiazole analogues and uses thereof in the treatment of cancer
|
|
ITMI20052008A1
(it)
|
2005-10-21 |
2007-04-22 |
Ctg Pharma S R L |
Nuovi antimalarici derivati della 4-aminochinolina
|
|
FR2902100A1
(fr)
|
2006-06-13 |
2007-12-14 |
Sanofi Aventis Sa |
Molecules duales contenant un derive peroxydique, leur synthese et leurs applications en therapeutique
|
|
US7511063B2
(en)
|
2006-08-16 |
2009-03-31 |
Schering Corporation |
High affinity quinoline-based kinase ligands
|
|
JP2008063278A
(ja)
|
2006-09-07 |
2008-03-21 |
Fujifilm Finechemicals Co Ltd |
１−ピリジン−４−イル−インドール類の製造方法
|
|
WO2008033748A2
(en)
|
2006-09-11 |
2008-03-20 |
Curis, Inc. |
Quinazoline based egfr inhibitors containing a zinc binding moiety
|
|
SG174772A1
(en)
|
2006-09-11 |
2011-10-28 |
Curis Inc |
Multi-functional small molecules as anti-proliferative agents
|
|
BRPI0715016A2
(pt)
|
2006-09-11 |
2013-05-28 |
Curis Inc |
composiÇço, composiÇço farmacÊutica, mÉtodo para tratar uma doenÇa ou distérbio relacionada com tirosina quinase de egfr em um individuo necessitando o mesmo, mÉtodo para tratar uma doenÇa mediada por hdac e mÉtodo para tratar doenÇas medidas tanto por tirosina quinase de egfr quanto hdac
|
|
TW200829555A
(en)
|
2006-11-10 |
2008-07-16 |
Astrazeneca Ab |
Chemical compounds
|
|
US8163923B2
(en)
|
2007-03-14 |
2012-04-24 |
Advenchen Laboratories, Llc |
Spiro substituted compounds as angiogenesis inhibitors
|
|
US8148532B2
(en)
|
2007-03-14 |
2012-04-03 |
Guoqing Paul Chen |
Spiro substituted compounds as angiogenesis inhibitors
|
|
US20080234267A1
(en)
|
2007-03-20 |
2008-09-25 |
Karen Elizabeth Lackey |
Compounds and Methods of Treatment
|
|
WO2008119771A2
(en)
|
2007-03-30 |
2008-10-09 |
Clanotech Ab |
Quinoline-s-carboxylic acid derivatives as tyrosine kinase inhibitors
|
|
KR20100015886A
(ko)
|
2007-04-23 |
2010-02-12 |
사노피-아벤티스 |
Ｐ2ｙ12 길항제로서의 퀴놀린-카복스아미드 유도체
|
|
PE20090717A1
(es)
|
2007-05-18 |
2009-07-18 |
Smithkline Beecham Corp |
Derivados de quinolina como inhibidores de la pi3 quinasa
|
|
PT3002009T
(pt)
|
2007-06-01 |
2021-08-02 |
Wyeth Llc |
Tratamento de leucemia mielógena crónica resistente a imatinib tendo amutação 1457t>c no gene bcrabl utilizando o composto bosutinib
|
|
CN101362719B
(zh)
|
2007-08-06 |
2012-04-18 |
北京师范大学 |
喹啉类衍生物以及包含其的组合物
|
|
US7939546B2
(en)
|
2007-10-12 |
2011-05-10 |
Supergen, Inc. |
Quinoline derivatives for modulating DNA methylation
|
|
US7790746B2
(en)
|
2007-10-12 |
2010-09-07 |
Supergen, Inc. |
Quinoline derivatives for modulating DNA methylation
|
|
EP2072502A1
(de)
|
2007-12-20 |
2009-06-24 |
Bayer Schering Pharma Aktiengesellschaft |
Sulfoximid-substituierte Chinolin- und Chinazolinderivate als Kinase-Inhibitoren
|
|
GB0801416D0
(en)
|
2008-01-25 |
2008-03-05 |
Piramed Ltd |
Pharmaceutical compounds
|
|
JP2011513427A
(ja)
|
2008-03-06 |
2011-04-28 |
ジェネンテック， インコーポレイテッド |
ｃ−ｍｅｔ及びＥＧＦＲアンタゴニストの併用療法
|
|
US20110262436A1
(en)
|
2008-10-17 |
2011-10-27 |
Genentech, Inc. |
Treatment method
|
|
DE102008062566A1
(de)
|
2008-12-16 |
2010-06-17 |
Bayer Schering Pharma Aktiengesellschaft |
Aminosäureester-Prodrugs und ihre Verwendung
|
|
PH12012500097A1
(en)
|
2009-07-21 |
2011-01-27 |
Shanghai Inst Organic Chem |
Potent small molecule inhibitors of autophagy, and methods of use thereof
|
|
US20130005726A1
(en)
|
2010-03-08 |
2013-01-03 |
Derek Abbott |
Compositions and methods for treating inflammatory disorders
|
|
US20130023532A1
(en)
|
2010-03-26 |
2013-01-24 |
Casillas Linda N |
Indazolyl-pyrimidines as kinase inhibitors
|
|
JP2013523658A
(ja)
|
2010-03-26 |
2013-06-17 |
グラクソ グループ リミテッド |
キナーゼ阻害剤としてのピラゾリル‐ピリミジン
|
|
EP2552208A4
(en)
|
2010-03-31 |
2014-07-09 |
Glaxo Group Ltd |
IMIDAZOLYL-IMIDAZOLES AS KINASE INHIBITORS
|
|
ES2552977T3
(es)
|
2010-05-07 |
2015-12-03 |
Glaxosmithkline Intellectual Property Development Limited |
Amino-quinolinas como inhibidores de quinasa
|
|
UY33549A
(es)
|
2010-08-10 |
2012-01-31 |
Glaxo Group Ltd |
Quinolil aminas como agentes inhibidores de las quinasas
|
|
WO2012027495A1
(en)
*
|
2010-08-27 |
2012-03-01 |
University Of The Pacific |
Piperazinylpyrimidine analogues as protein kinase inhibitors
|
|
MY181439A
(en)
|
2011-02-28 |
2020-12-22 |
Sunshine Lake Pharma Co Ltd |
Substituted quinoline compounds and methods of use
|
|
CN103857288B
(zh)
*
|
2011-03-04 |
2016-09-21 |
葛兰素史密斯克莱知识产权发展有限公司 |
作为激酶抑制剂的氨基-喹啉
|
|
TWI547494B
(zh)
|
2011-08-18 |
2016-09-01 |
葛蘭素史克智慧財產發展有限公司 |
作為激酶抑制劑之胺基喹唑啉類
|
|
AR092530A1
(es)
|
2012-09-13 |
2015-04-22 |
Glaxosmithkline Llc |
Compuesto de amino-quinolina, composicion farmaceutica que lo comprende y uso de dicho compuesto para la preparacion de un medicamento
|
|
AR092529A1
(es)
|
2012-09-13 |
2015-04-22 |
Glaxosmithkline Llc |
Compuesto de aminoquinazolina, composicion farmaceutica que lo comprende y uso de dicho compuesto para la preparacion de un medicamento
|
|
EP2958911B1
(en)
|
2013-02-21 |
2017-10-18 |
GlaxoSmithKline Intellectual Property Development Limited |
Quinazolines as kinase inhibitors
|